Oct 5 (Reuters) - FSD Pharma Inc HUGE.CD :
* FSD PHARMA BEGINS PHASE 2 CLINICAL TRIAL TO EVALUATE FSD201 FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS
* FSD PHARMA INC - EXPECTED TO START DOSING PATIENTS IN OCTOBER 2020 FOR FSD201
* FSD PHARMA INC - FDA HAS AUTHORIZED INITIATION OF A PHASE 2 STUDY FOR USE OF FSD201 TO TREAT COVID-19